Trial intelligence / Profile preview

DEXCOEUR: Dexmedetomidine in Outpatient Surgery

NCT06082856Recruiting

Sponsor
CHU Nîmes
Start
Oct 2023
Primary completion
Feb 2026
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of dexmedetomidine in Anesthesia (2 arms), sponsored by CHU Nîmes. Primary endpoint: Intraoperative hemodynamic stability during anesthesia between groups. Started Oct 2023; status: recruiting.

02

Drugs

dexmedetomidine
03

Conditions

Anesthesia

Beyond the preview

Go deeper on NCT06082856.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06082856.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call